Bausch Health Companies (BHC) Shares Outstanding (2009 - 2026)
Bausch Health Companies (BHC) posted Shares Outstanding (Entity) of $373.9 million for Q2 2026, little changed sequentially from $373.5 million in Q1 2026, and up 1.12% YoY from $369.7 million in Q2 2025.
Bausch Health Companies (BHC) Shares Outstanding (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Shares Outstanding (Entity) for 18 years, with the latest figure at $373.9 million in Q2 2026.
- Quarterly Shares Outstanding (Entity) rose 1.12% year-over-year to $373.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $373.9 million (up 1.12% YoY) and the FY2025 annual result came in at $370.5 million, up 0.73% from the prior year.
- Shares Outstanding (Entity) held at $373.9 million in Q2 2026 per BHC's latest filing, from $373.5 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $373.9 million in Q2 2026 and troughed at $361.3 million in Q1 2022.
- A 5-year average of $366.7 million and a median of $366.8 million in 2024 frame the typical range for Shares Outstanding (Entity).
- The sharpest annual moves came in 2023 and 2026: Shares Outstanding (Entity) increased 0.63% in 2023, then gained 1.12% in 2026.
- Over 5 years, Shares Outstanding (Entity) stood at $361.9 million in 2022, then gained by 0.92% to $365.2 million in 2023, then rose by 0.71% to $367.8 million in 2024, then grew by 0.73% to $370.5 million in 2025, then climbed by 0.91% to $373.9 million in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $373.9 million, $373.5 million, and $370.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 832.44 Mn |
| 10 | Bausch Health Companies | 2.58 Bn | 738.25 Mn | 2.10 Bn | 375.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 375.00 Mn |
| Mar 31, 2026 | 372.80 Mn |
| Dec 31, 2025 | 370.90 Mn |
| Sep 30, 2025 | 371.30 Mn |
| Jun 30, 2025 | 370.90 Mn |
| Mar 31, 2025 | 369.60 Mn |
| Dec 31, 2024 | 368.00 Mn |
| Sep 30, 2024 | 368.40 Mn |
| Jun 30, 2024 | 367.90 Mn |
| Mar 31, 2024 | 366.80 Mn |
| Dec 31, 2023 | 364.90 Mn |
| Sep 30, 2023 | 365.40 Mn |
| Jun 30, 2023 | 364.80 Mn |
| Mar 31, 2023 | 363.30 Mn |
| Dec 31, 2022 | 362.00 Mn |
| Sep 30, 2022 | 362.50 Mn |
| Jun 30, 2022 | 362.20 Mn |
| Mar 31, 2022 | 360.80 Mn |
| Dec 31, 2021 | 358.90 Mn |
| Sep 30, 2021 | 359.60 Mn |